Also enjoy cooking and tech / Cybersercurity / AvGeek stuff..
6/x
6/x
5/x
5/x
4/x
4/x
– double total deaths among 30-34 year olds within 13 years
– increase them 10-fold within 24 years
3/x
– double total deaths among 30-34 year olds within 13 years
– increase them 10-fold within 24 years
3/x
2/x
2/x
1/x
1/x
GGG remains your loyal foodie account.
GGG remains your loyal foodie account.
- this chart includes reasons of deaths showing growth vs. 2019 only
1/x
- this chart includes reasons of deaths showing growth vs. 2019 only
1/x
- 1.85% per year (1998-2009)
- 1.95% per year (2009-2015)
- 3.49% per year (2015-2019) (0.5x in 19 years)
2/x
- 1.85% per year (1998-2009)
- 1.95% per year (2009-2015)
- 3.49% per year (2015-2019) (0.5x in 19 years)
2/x
It was never about protecting the healthcare system.
It was always about further reducing the number of patient days.
Nothing - and I mean NOTHING - was allowed to stand in the way of that overall goal.
1/x
It was never about protecting the healthcare system.
It was always about further reducing the number of patient days.
Nothing - and I mean NOTHING - was allowed to stand in the way of that overall goal.
1/x
- 1. dose: 81% coverage
- 2. dose: 78%
- 3. dose: 56%
- 4. dose: 25%
as the remaining population was left to get a "brush with nature" (a term launched by Finland's CDC).
1/x
- 1. dose: 81% coverage
- 2. dose: 78%
- 3. dose: 56%
- 4. dose: 25%
as the remaining population was left to get a "brush with nature" (a term launched by Finland's CDC).
1/x
- R06 (abnormalities of breathing): 21.5% average growth (10x in 11.8 years)
4/x
- R06 (abnormalities of breathing): 21.5% average growth (10x in 11.8 years)
4/x
www.nature.com/immersive/d4...
www.nature.com/immersive/d4...
3/x
3/x
2/x
2/x
- <1 year olds: 21.8% per year (10x in 11.7 years) (100% unvaccinated)
- 1-6 year olds: 21.3% per year (10x in 11.9 years)
1/x
- <1 year olds: 21.8% per year (10x in 11.7 years) (100% unvaccinated)
- 1-6 year olds: 21.3% per year (10x in 11.9 years)
1/x
- total growth 5.7% per year (2019-2025e) although population age restricted; something else than ageing is driving growth
Fastest growth rates (2019-2025e):
- systemic atrophies (G10-13, incl. ALS, ataxia) 14.3%
- other disorders of NS (G90-G99) 13.7%
14/x
- total growth 5.7% per year (2019-2025e) although population age restricted; something else than ageing is driving growth
Fastest growth rates (2019-2025e):
- systemic atrophies (G10-13, incl. ALS, ataxia) 14.3%
- other disorders of NS (G90-G99) 13.7%
14/x
- inflammatory CNS (central nervous system) diseases showing fastest patient growth: 19.2% per year (2020-2025e) and 32.8% in 2025e
- systemic atrophies (G10-13, including ALS and ataxia) showing strong growth
- lower total growth (7.2%): capacity rationing?
13/x
- inflammatory CNS (central nervous system) diseases showing fastest patient growth: 19.2% per year (2020-2025e) and 32.8% in 2025e
- systemic atrophies (G10-13, including ALS and ataxia) showing strong growth
- lower total growth (7.2%): capacity rationing?
13/x
- dominant driver: episodic & paraxysmal disorders (G40-47)
- fastest growth in 2025e: inflammatory diseases of the central nervous system (G00-09) (44.8% growth in 2025e)
- degenerative (G30-32) and movement disorders (G20-26) are showing steady growth
12/x
- dominant driver: episodic & paraxysmal disorders (G40-47)
- fastest growth in 2025e: inflammatory diseases of the central nervous system (G00-09) (44.8% growth in 2025e)
- degenerative (G30-32) and movement disorders (G20-26) are showing steady growth
12/x